WMT raises €2.0M Seed round
31 October 2020· Heidelberg, Germany· health, oncology, biotech, b2b, deep_hardware
The seed funding was raised to discover and develop small-molecule drug candidates targeting protein translation for the treatment of cancer and inflammatory diseases.
Investors
LeadCarma Fund
Also participating
GIMIC VenturesFS Life Science Investment
About WMT
Stage
Series A
Headquarters
Heidelberg, Germany
Founded
2020
Team Size
6–20
Sectors
healthoncologybiotechb2bdeep_hardware